Inventor · disambiguated record
Fabian Dey
Also filed as: DEY FABIAN
26 granted patents·28 pending applications·59 citations·filing 2014–2025
94Inventor score
Files withHOFFMANN LA ROCHE35C4 THERAPEUTICS INC13RODIN THERAPEUTICS INC3ALKERMES INC2UNIV COLUMBIA1
Top patents by PatentIndex Score
54 records- 0197US11584748B2Spirocyclic compoundsC4 THERAPEUTICS INC·Filed 2020·Granted Feb 21, 2023·11 cites·11 claims
- 0296US11623929B2Spirocyclic compoundsC4 THERAPEUTICS INC·Filed 2020·Granted Apr 11, 2023·7 cites·20 claims
- 0394US11254672B2Dihydrobenzimidazolones for medical treatmentC4 THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·7 cites·22 claims
- 0493US11802131B2Glutarimides for medical treatmentC4 THERAPEUTICS INC·Filed 2020·Granted Oct 31, 2023·4 cites·9 claims
- 0593US11787802B2Dihydrobenzimidazolones for medical treatmentC4 THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·3 cites·19 claims
- 0693US10919902B2Hetero-halo inhibitors of histone deacetylaseALKERMES INC·Filed 2019·Granted Feb 16, 2021·4 cites·1 claims
- 0792US11401256B2Dihydroquinolinones for medical treatmentC4 THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·5 cites·26 claims
- 0892US10421756B2Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2016·Granted Sep 24, 2019·9 cites·13 claims
- 0987US12091397B2Dihydroquinolinones for medical treatmentC4 THERAPEUTICS INC·Filed 2022·Granted Sep 17, 2024·1 cites·13 claims
- 1086US9981920B2Inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2015·Granted May 29, 2018·7 cites·11 claims
- 1179US12365681B2Dihydrobenzimidazolones for medical treatmentC4 THERAPEUTICS INC·Filed 2023·Granted Jul 22, 2025·0 cites·16 claims
- 1279US12227504B2Spirocyclic compoundsC4 THERAPEUTICS INC·Filed 2023·Granted Feb 18, 2025·0 cites·13 claims
- 1377US2025084055A1Dihydroquinolinones for medical treatmentC4 THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1475US11713327B2Heteroaryl heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Aug 1, 2023·1 cites·17 claims
- 1573US11858939B2Hetero-halo inhibitors of histone deacetylaseALKERMES INC·Filed 2020·Granted Jan 2, 2024·0 cites·1 claims
- 1671US2024018156A1Spirocyclic compoundsC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1770US2025282780A1Spirocyclic compoundsC4 THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1869US2024199638A1Glutarimides for medical treatmentC4 THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1966US2024360126A1Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2065US2024140933A1Oxoindoline compound for the treatment of inflammatory diseases or cancerHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2163US11046671B2Dihydropyrimidinyl benzazepine carboxamide compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 2259US2025011300A1Piperazinylsulfonylaryl compounds for treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2358US10590112B2Dihydropyrimidinyl benzazepine carboxamide compoundsHOFFMANN LA ROCHE·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 2457US12503471B2Triazatricycle compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 23, 2025·0 cites·15 claims
- 2557US12486273B2Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 2, 2025·0 cites·18 claims
- 2657US2024417387A1Sulfonylpiperazinyl compounds for treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2756US12421229B2Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Sep 23, 2025·0 cites·13 claims
- 2856US2014258207A1Systems and Methods for Predicting Protein-Ligand InteractionsUNIV COLUMBIA·Filed 2014·Application pending·0 cites
- 2956US2023295109A1Pyridinone compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3056US2020339603A1Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3155US2023279001A1Imidazo[1,2-a]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3255US2024317735A1Hydroisoquinoline or hydronaphthyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3354US2021317141A1Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3454US2021309657A1Tricyclic compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3554US2021309658A1Aryl compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3653US11952363B2Piperazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Apr 9, 2024·0 cites·14 claims
- 3753US2021323981A1Free amino compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3852US12252484B2Pyrazolopyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Mar 18, 2025·0 cites·17 claims
- 3952US11639352B2Benzothiazole compounds for the treatment of autoimmune diseasesHOFFMANN LA ROCHE·Filed 2018·Granted May 2, 2023·0 cites·12 claims
- 4052US11548884B2Cyclic amidine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Jan 10, 2023·0 cites·12 claims
- 4152US2021269451A1Pyridinyl heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 4252US2023002375A1Hydropyrazino[1,2-b]isoquinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4351US2021238197A1Novel oxoquinolizine compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4451US2022363665A1Quinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4550US2018194769A1Hetero-halo inhibitors of histone deacetylaseRODIN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4649US12157746B2Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Dec 3, 2024·0 cites·19 claims
- 4749US10662203B2Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2018·Granted May 26, 2020·0 cites·27 claims
- 4848US2022340597A1Hexahydro-1h-pyrazino[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4947US11091514B2Peptide macrocycles and use thereof in the treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2019·Granted Aug 17, 2021·0 cites·11 claims
- 5046US2021395239A1Heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Fabian Dey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →